Controversies in Oral Cancer

Despite considerable advances in the traditional treatment modalities of surgery, radiation and chemotherapy, and their use in combination, increments in overall survival among persons with oral cancer have been small. Morbidity due to treatment adversely affects the quality of life. This volume brings together the work of experts from clinical and basic sciences specialties and addresses some of the controversial issues and advances in the management of oral cancer.

Kumar Alok Pathak is Professor of Surgery and Director of Surgical Fellowships at the University of Manitoba in Winnipeg, Canada. He also practises as Head and Neck Surgical Oncologist at CancerCare Manitoba. Earlier, Dr Pathak served as a Professor of Surgical Oncology at Tata Memorial Hospital, Mumbai, India. He trained at the Banaras Hindu University and Tata Memorial Hospital, India and Memorial Sloan-Kettering Cancer Center, New York. His main areas of interest are clinical and translational research in oral and thyroid cancers.

Richard W. Nason is Professor and Head, Department of Surgery at the University of Manitoba, and the Regional Medical Director, Surgery Program, Winnipeg Regional Health Authority. He has practised as a Head and Neck Surgical Oncologist at CancerCare Manitoba since 1993, and earlier served as the Head of Surgical Oncology and chaired the Head and Neck Disease Site Group. Dr Nason did his residency in General Surgery at the University of Alberta, Canada; and a fellowship in Head and Neck Surgical Oncology at Roswell Park Memorial Institute, New York. His clinical and research focus has always been on head and neck cancer.